Display options
Share it on

Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):e626-e629. doi: 10.1016/j.clml.2021.03.003. Epub 2021 Mar 18.

Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular Lymphoma.

Clinical lymphoma, myeloma & leukemia

Mahsa Khanlari, Sa A Wang, Nathan H Fowler, Guilin Tang, Karan Saluja, Tariq Muzzafar, L Jeffrey Medeiros, Beenu Thakral

Affiliations

  1. Department of Hematopathology, MD Anderson Cancer Center, Houston, TX.
  2. Department of Lymphoma and Myeloma Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX.
  3. Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, TX.
  4. Department of Hematopathology, MD Anderson Cancer Center, Houston, TX. Electronic address: [email protected].

PMID: 33867306 DOI: 10.1016/j.clml.2021.03.003

[No abstract available.]

Keywords: Deletion; Follicular lymphoma; Low-grade lymphoma; Mutation; TP53

Publication Types